Early detection of recurrent hepatocellular carcinoma

Takashi Nishizaki, Kenji Takenaka, Katsuhiko Yanaga, Yuji Soejima, Hideaki Uchiyama, Keiji Kishikawa, Keizo Sugimachi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background/Aims: Early detection and treatment of recurrent hepatocellular carcinoma (HCC) are keys to patient survival after hepatic resection. In attempts at early detection, we make use of the alpha-fetoprotein (AFP) test every month and abdominal ultrasound (US) and computed tomography (CT) are carried out every three months after hepatectomy. The objective of the present study was to evaluate the most appropriate interval for follow-up re-examinations after resection for HCC. Patients and Methods: Eighty-five patients with recurrent HCC were divided into two groups according to the state of the tumor when recurrence was detected: Group I (n = 70); tumor size ≤ 2.0 cm, and group II (n = 15) tumor size ≤ 2.1 cm. Clinicopathological comparisons were made between the two groups. Results: AFP positivity in group I was significantly lower than group II at the time of recurrence. Rates of extrahepatic intra-abdominal recurrences, i.e. recurrence at the surgical stump and in the abdominal cavity and lymph nodes around the liver, were more frequent ingroup II than, in group I (47% vs 4%; p < 0.001). The average tumor size was larger in 10 patients with extrahepatic intra-abdominal recurrence than, in 75 patients with intrahepatic recurrence (3.4 ± 2.0 vs 1.6 ± 0.6 cm; p < 0.0001). There was a statistically significant difference regarding the histological grade of initial HCC between the two patterns of recurrence. Conclusions: Measurements of AFP were seen to have limited value for detecting recurrence, at an early stage. Close postoperative follow-up, including bedside US in the outpatient clinic, should be carried out when the initial HCC is histologically less differentiated HCC.

Original languageEnglish
Pages (from-to)508-513
Number of pages6
JournalHepato-Gastroenterology
Volume44
Issue number14
Publication statusPublished - May 3 1997

Fingerprint

Hepatocellular Carcinoma
Recurrence
alpha-Fetoproteins
Neoplasms
Abdominal Cavity
Liver
Hepatectomy
Ambulatory Care Facilities
Lymph Nodes
Tomography
Survival

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Nishizaki, T., Takenaka, K., Yanaga, K., Soejima, Y., Uchiyama, H., Kishikawa, K., & Sugimachi, K. (1997). Early detection of recurrent hepatocellular carcinoma. Hepato-Gastroenterology, 44(14), 508-513.

Early detection of recurrent hepatocellular carcinoma. / Nishizaki, Takashi; Takenaka, Kenji; Yanaga, Katsuhiko; Soejima, Yuji; Uchiyama, Hideaki; Kishikawa, Keiji; Sugimachi, Keizo.

In: Hepato-Gastroenterology, Vol. 44, No. 14, 03.05.1997, p. 508-513.

Research output: Contribution to journalArticle

Nishizaki, T, Takenaka, K, Yanaga, K, Soejima, Y, Uchiyama, H, Kishikawa, K & Sugimachi, K 1997, 'Early detection of recurrent hepatocellular carcinoma', Hepato-Gastroenterology, vol. 44, no. 14, pp. 508-513.
Nishizaki T, Takenaka K, Yanaga K, Soejima Y, Uchiyama H, Kishikawa K et al. Early detection of recurrent hepatocellular carcinoma. Hepato-Gastroenterology. 1997 May 3;44(14):508-513.
Nishizaki, Takashi ; Takenaka, Kenji ; Yanaga, Katsuhiko ; Soejima, Yuji ; Uchiyama, Hideaki ; Kishikawa, Keiji ; Sugimachi, Keizo. / Early detection of recurrent hepatocellular carcinoma. In: Hepato-Gastroenterology. 1997 ; Vol. 44, No. 14. pp. 508-513.
@article{528c455b4cc24663acd3ed38858e587c,
title = "Early detection of recurrent hepatocellular carcinoma",
abstract = "Background/Aims: Early detection and treatment of recurrent hepatocellular carcinoma (HCC) are keys to patient survival after hepatic resection. In attempts at early detection, we make use of the alpha-fetoprotein (AFP) test every month and abdominal ultrasound (US) and computed tomography (CT) are carried out every three months after hepatectomy. The objective of the present study was to evaluate the most appropriate interval for follow-up re-examinations after resection for HCC. Patients and Methods: Eighty-five patients with recurrent HCC were divided into two groups according to the state of the tumor when recurrence was detected: Group I (n = 70); tumor size ≤ 2.0 cm, and group II (n = 15) tumor size ≤ 2.1 cm. Clinicopathological comparisons were made between the two groups. Results: AFP positivity in group I was significantly lower than group II at the time of recurrence. Rates of extrahepatic intra-abdominal recurrences, i.e. recurrence at the surgical stump and in the abdominal cavity and lymph nodes around the liver, were more frequent ingroup II than, in group I (47{\%} vs 4{\%}; p < 0.001). The average tumor size was larger in 10 patients with extrahepatic intra-abdominal recurrence than, in 75 patients with intrahepatic recurrence (3.4 ± 2.0 vs 1.6 ± 0.6 cm; p < 0.0001). There was a statistically significant difference regarding the histological grade of initial HCC between the two patterns of recurrence. Conclusions: Measurements of AFP were seen to have limited value for detecting recurrence, at an early stage. Close postoperative follow-up, including bedside US in the outpatient clinic, should be carried out when the initial HCC is histologically less differentiated HCC.",
author = "Takashi Nishizaki and Kenji Takenaka and Katsuhiko Yanaga and Yuji Soejima and Hideaki Uchiyama and Keiji Kishikawa and Keizo Sugimachi",
year = "1997",
month = "5",
day = "3",
language = "English",
volume = "44",
pages = "508--513",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "14",

}

TY - JOUR

T1 - Early detection of recurrent hepatocellular carcinoma

AU - Nishizaki, Takashi

AU - Takenaka, Kenji

AU - Yanaga, Katsuhiko

AU - Soejima, Yuji

AU - Uchiyama, Hideaki

AU - Kishikawa, Keiji

AU - Sugimachi, Keizo

PY - 1997/5/3

Y1 - 1997/5/3

N2 - Background/Aims: Early detection and treatment of recurrent hepatocellular carcinoma (HCC) are keys to patient survival after hepatic resection. In attempts at early detection, we make use of the alpha-fetoprotein (AFP) test every month and abdominal ultrasound (US) and computed tomography (CT) are carried out every three months after hepatectomy. The objective of the present study was to evaluate the most appropriate interval for follow-up re-examinations after resection for HCC. Patients and Methods: Eighty-five patients with recurrent HCC were divided into two groups according to the state of the tumor when recurrence was detected: Group I (n = 70); tumor size ≤ 2.0 cm, and group II (n = 15) tumor size ≤ 2.1 cm. Clinicopathological comparisons were made between the two groups. Results: AFP positivity in group I was significantly lower than group II at the time of recurrence. Rates of extrahepatic intra-abdominal recurrences, i.e. recurrence at the surgical stump and in the abdominal cavity and lymph nodes around the liver, were more frequent ingroup II than, in group I (47% vs 4%; p < 0.001). The average tumor size was larger in 10 patients with extrahepatic intra-abdominal recurrence than, in 75 patients with intrahepatic recurrence (3.4 ± 2.0 vs 1.6 ± 0.6 cm; p < 0.0001). There was a statistically significant difference regarding the histological grade of initial HCC between the two patterns of recurrence. Conclusions: Measurements of AFP were seen to have limited value for detecting recurrence, at an early stage. Close postoperative follow-up, including bedside US in the outpatient clinic, should be carried out when the initial HCC is histologically less differentiated HCC.

AB - Background/Aims: Early detection and treatment of recurrent hepatocellular carcinoma (HCC) are keys to patient survival after hepatic resection. In attempts at early detection, we make use of the alpha-fetoprotein (AFP) test every month and abdominal ultrasound (US) and computed tomography (CT) are carried out every three months after hepatectomy. The objective of the present study was to evaluate the most appropriate interval for follow-up re-examinations after resection for HCC. Patients and Methods: Eighty-five patients with recurrent HCC were divided into two groups according to the state of the tumor when recurrence was detected: Group I (n = 70); tumor size ≤ 2.0 cm, and group II (n = 15) tumor size ≤ 2.1 cm. Clinicopathological comparisons were made between the two groups. Results: AFP positivity in group I was significantly lower than group II at the time of recurrence. Rates of extrahepatic intra-abdominal recurrences, i.e. recurrence at the surgical stump and in the abdominal cavity and lymph nodes around the liver, were more frequent ingroup II than, in group I (47% vs 4%; p < 0.001). The average tumor size was larger in 10 patients with extrahepatic intra-abdominal recurrence than, in 75 patients with intrahepatic recurrence (3.4 ± 2.0 vs 1.6 ± 0.6 cm; p < 0.0001). There was a statistically significant difference regarding the histological grade of initial HCC between the two patterns of recurrence. Conclusions: Measurements of AFP were seen to have limited value for detecting recurrence, at an early stage. Close postoperative follow-up, including bedside US in the outpatient clinic, should be carried out when the initial HCC is histologically less differentiated HCC.

UR - http://www.scopus.com/inward/record.url?scp=0030998592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030998592&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 508

EP - 513

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 14

ER -